Bradykinin-induced blood-brain tumor barrier permeability increase is mediated by adenosine 5′-triphosphate-sensitive potassium channel

Brain Research

Volumn 1144, Issue 1, 2007, Pages 33-41

  Zhang, Hua ^a   Ting Gu, Yan ^a   Xue, Yi Xue ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Blood brain barrier; Bradykinin; Glioma; KATP channel

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; BRADYKININ; GLIBENCLAMIDE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TUMOR; CELL CULTURE; CONTROLLED STUDY; FEMALE; GLIOMA; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; MODULATION; NONHUMAN; PATCH CLAMP; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; WHOLE CELL;

ADENOSINE TRIPHOSPHATE; ANIMALS; BLOOD-BRAIN BARRIER; BRADYKININ; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION; GLIOMA; GLYBURIDE; MEMBRANE POTENTIALS; NEOPLASM METASTASIS; PATCH-CLAMP TECHNIQUES; PERMEABILITY; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RATS, WISTAR; TIME FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

RATTUS;

EID: 33947305301     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.01.133     Document Type: Article

References (47)

1. + channels in cGMP mediated pial artery vasodilation. Am. J. Physiol. 270 (1996) H423-H426
2. Armstead W.M. Role of nitric oxide, cyclic nucleotides, and the activation of ATP-sensitive K+ channels in the contribution of adenosine to hypoxia-induced pial artery dilation. J. Cereb. Blood Flow Metab. 17 (1997) 100-108
3. Asotra K., and Black K.L. Blood-brain barrier as portal for drug delivery. Adv. Clin. Neurosci. 10 (2000) 323-339
4. Bachvarov D.R., Houle S., Bachvarova M., Bouthillier J., Adam A., and Marceau F. Bradykinin B2 receptor endocytosis, recycling, and down-regulation assessed using green fluorescent protein conjugates. J. Pharmacol. Exp. Ther. 297 (2001) 19-26
5. Bartus R.T. The blood-brain barrier as a target for pharmacological modulation. Curr. Opin. Drug Discov. Dev. 2 (1999) 152-167
6. Bartus R.T., Elliott P., Hayward N., Dean R., McEwen E.L., and Fisher S.K. Permeability of the blood brain barrier by the bradykinin agonist, RMP-7: evidence for a sensitive, auto-regulated, receptor-mediated system. Immunopharmacology 33 (1996) 270-278
7. Bartus R.T., Snodgrass P., Dean R.L., Kordower J.H., and Emerich D.F. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies. Exp. Neurol. 161 (2000) 234-244
8. Bendayan R., Lee G., and Bendayan M. Functional expression and localization of P-glycoprotein at the blood-brain barrier. Microsc. Res. Tech. 57 (2002) 365-380
9. Bhoola K., Ramsaroop R., Plendl J., Cassim B., Dlamini Z., and Naicker S. Kallikrein and kinin receptor expression in inflammation and cancer. Biol. Chem. 382 (2001) 77-89
10. Black K.L., and Ningaraj N.S. Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor. Cancer Control 11 (2004) 165-173
11. Black K.L., Cloughesy T., Huang S.C., Gobin Y.P., Zhou Y., Grous J., Nelson G., Farahani K., Hoh C.K., and Phelps M. Intracarotid infusion of RMP-7, a bradykinin analog, increases transport of gallium-68 EDTA into human gliomas. J. Neurosurg. 86 (1997) 603-609
12. Elliott P.J., Hayward N.J., Dean R.L., Blunt D.G., and Bartus R.T. Intravenous RMP-7 selectively increases uptake of carboplatin into rat brain tumors. Cancer Res. 56 (1996) 3998-4005
13. Ford J., Miles K.A., Hayball M.P., Bearcroft P.W., Bleehen N.M., and Osborn C.S. A simplified technique for measurement of blood-brain barrier permeability using CT: preliminary results of the effect of RMP-7. Quantitative Imaging in Oncology (1996), British Institute of Radiology, London
14. Ford J., Osborn C., Barton T., and Bleehen N.M. A phase I study of intravenous Cereport (RMP-7) with carboplatin in patients with progression of malignant glioma. Eur. J. Cancer 34 (1998) 1807-1811
15. Gregor A., Lind M., Newman H., Grant R., Hadley D.M., Barton T., and Osborn C. Phase II studies of RMP-7 and carboplatin in the treatment of recurrent high grade glioma. J. Neurooncol. 44 (1999) 137-145
16. Grossi P.M., Ochiai H., Archer G.E., McLendon R.E., Zalutsky M.R., Friedman A.H., Friedman H.S., Bigner D.D., and Sampson J.H. Efficacy of intracerebral microinfusion of trastuzumab in an athymic rat model of intracerebral metastatic breast cancer. Clin. Cancer Res. 9 (2003) 5514-5520
17. Hashizume K., and Black K.L. Increased endothelial vesicular transport correlates with increased blood-tumor barrier permeability induced by bradykinin and leukotriene C4. J. Neuropathol. Exp. Neurol. 61 (2002) 725-735
18. ATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 270 (1995) 1166-1170
19. Inamura T., and Black K.L. Bradykinin selectively opens blood-tumor barrier in experimental brain tumors. J. Cereb. Blood Flow Metab. 14 (1994) 862-870
20. + channels in rat aorta and brain microvascular endothelial cells. Am. J. Physiol. 265 (1993) C812-C821
21. Lindauer U., Vogt J., Schuh-Hofer S., Dreier J.P., and Dirnagl U. Cerebrovascular vasodilation to extraluminal acidosis occurs via combined activation of ATP-sensitive and Ca2+-activated potassium channels. J. Cereb. Blood Flow Metab. 23 (2003) 1227-1238
22. Liu Y., Hashizume K., Chen Z., Samoto K., Ningaraj N., Asotra K., and Black K.L. Correlation between bradykinin-induced blood-tumor barrier permeability and B2 receptor expression in experimental brain tumors. Neurol. Res. 23 (2001) 379-387
23. Liu Y., Hashizume K., Samoto K., Sugita M., Ningaraj N., Asotra K., and Black K.L. Repeated, short-term ischemia augments bradykinin-mediated opening of the blood-tumor barrier in rats with RG2 glioma. Neurol. Res. 23 (2001) 631-640
24. Mackic J.B., Stins M., Jovanovic S., Kim K.S., Bartus R.T., and Zlokovic B.V. Cereport (RMP-7) increases the permeability of human brain microvascular endothelial cell monolayers. Pharm. Res. 16 (1999) 1360-1365
25. Maeda H., Akaike T., Wu J., Noguchi Y., and Sakata Y. Bradykinin and nitric oxide in infectious disease and cancer. Immunopharmacology 33 (1996) 222-230
26. Matsukado K., Inamura T., Nakano S., Fukui M., Bartus R.T., and Black K.L. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7. Neurosurgery 39 (1996) 125-133
27. Matsukado K., Sugita M., and Black K.L. Intracarotid low dose bradykinin infusion selectively increases tumor permeability through activation of bradykinin B2 receptors in malignant gliomas. Brain Res. 792 (1998) 10-15
28. Nakano S., Matsukado K., and Black K.L. Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide?. Cancer Res. 56 (1996) 4027-4031
29. Nichols C.G., and Lopatin A.N. Inward rectifier potassium channels. Annu. Rev. Physiol. 59 (1997) 171-191
30. Ningaraj N.S., Rao M., Hashizume K., Asotra K., and Black K.L. Regulation of blood-brain tumor barrier permeability by calcium-activated potassium channels. J. Pharmacol. Exp. Ther. 301 (2002) 838-851
31. Ningaraj N.S., Rao M.K., and Black K.L. Adenosine 5-triphosphate-sensitive potassium channel-mediated blood-brain tumor barrier permeability increase in a rat brain tumor model. Cancer Res. 63 (2003) 8899-8911
32. Nishio S., Ohta M., Abe K., and Kitamura K. Microvascular abnormalities in ethylnitrosourea (ENU)-induced rat brain tumors: structural basis for altered blood-brain barrier function. Acta Neuropathol. 59 (1983) 1-10
33. Nomura T., Inamura T., and Black K. Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors. Brain Res. 658 (1994) 62-66
34. Pizard A., Blaukat A., Muller-Esterl W., Alhenc-Gelas F., and Rajerison R.M. Bradykinin-induced internalization of the human B2 receptor requires phosphorylation of three serine and two threonine residues at its carboxyl tail. J. Biol. Chem. 274 (1999) 12738-12747
35. Raidoo D.M., Sawant S., Mahabeer R., and Bhoola K.D. Kinin receptors are expressed in human astrocytic tumour cells. Immunopharmacology 43 (1999) 255-263
36. Sakura H., Ammala C., Smith P.A., Gribble F.M., and Ashcroft F.M. Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic beta-cells, brain, heart, and skeletal muscle. FEBS Lett. 377 (1995) 338-344
37. Schnitzler M.M., Derst C., Daut J., and Preisig-Muller R. ATP-sensitive potassium channels in capillaries isolated from guinea-pig heart. J. Physiol. 525 Pt 2 (2000) 307-317
38. Siddik Z., Grous J., Chang S., Barker F., Huhn S., Nicholas M., Rabbitt J., Page M., Graney W., and Prados M. Pharmacokinetics of carboplatin and RMP-7 in patients with recurrent malignant glioma. ASCO Annual Meeting, Philadelphia (1996)
39. Sugita M., and Black K.L. Cyclic GMP-specific phosphodiesterase inhibition and intracarotid bradykinin infusion enhances permeability into brain tumors. Cancer Res. 58 (1998) 914-920
40. Sugita M., Hunt G.E., Liu Y., and Black K.L. Nitric oxide and cyclic GMP attenuate sensitivity of the blood-tumor barrier permeability to bradykinin. Neurol. Res. 20 (1998) 559-563
41. Uchida M., Chen Z., Liu Y., and Black K.L. Overexpression of bradykinin type 2 receptors on glioma cells enhances bradykinin-mediated blood-brain tumor barrier permeability increase. Neurol. Res. 24 (2002) 739-746
42. Virgintino D., Robertson D., Errede M., Benagiano V., Girolamo F., Maiorano E., Roncali M., and Bertossi M. Expression of P-glycoprotein in human cerebral cortex microvessels. J. Histochem. Cytochem. 50 (2002) 1671-1676
43. Vorbrodt A.W. Ultrastructural cytochemistry of blood-brain barrier endothelia. Prog. Histochem. Cytochem. 18 (1988) 1-99
44. Wang P., and Xue Y.X. Relationship between drug treatment time and bradykinin B2 receptor internalization in glioma cells. Chin. J. Cancer Prev. Treat. 12 (2005) 167-171
45. Wu J., Akaike T., Hayashida K., Miyamoto Y., Nakagawa T., Miyakawa K., Muller-Esterl W., and Maeda H. Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues. Int. J. Cancer 98 (2002) 29-35
46. Yokoshiki H., Sunagawa M., Seki T., and Sperelakis N. ATP-sensitive K+ channels in pancreatic, cardiac and vascular smooth muscle cells. Am. J. Physiol. 274 (1998) C25-C37
47. Zhao Y., Xue Y., Liu Y., Fu W., Jiang N., An P., Wang P., Yang Z., and Wang Y. Study of correlation between expression of bradykinin B2 receptor and pathological grade in human gliomas. Br. J. Neurosurg. 19 (2005) 322-326